Navigation Links
Landauer, Inc. Announces Executive Management Change
Date:8/22/2014

GLENWOOD, Ill., Aug. 22, 2014 /PRNewswire/ -- Landauer, Inc. (NYSE: LDR), a recognized leader in personal and environmental radiation measurement and monitoring, outsourced medical physics services and high quality medical consumable accessories, announced today that William E. Saxelby, its President and Chief Executive Officer, will be stepping down as President and Chief Executive Officer and as a member of the Board of Directors, effective as of September 15, 2014.  He will be replaced on an interim basis by Michael T. Leatherman, a member of the Company's Board of Directors since 2008.  The Board has commenced a search, which will consider internal and external candidates, for a permanent successor to Mr. Saxelby.  Mr. Saxelby has agreed to work with Mr. Leatherman in the near term in an advisory role.

"No one has worked harder than Bill to enhance the Landauer brand, expand Landauer's service offerings and extend the Company's reach into new markets.  We thank Bill for his dedicated leadership of Landauer over the past nine years and wish him well in all of his future endeavors," said Chairman of the Company's Board of Directors Robert J. Cronin

About Landauer
Landauer is a leading global provider of technical and analytical services to determine occupational and environmental radiation exposure, the leading domestic provider of outsourced medical physics services, as well as a provider of high quality medical accessories used in radiology, radiation therapy, and image guided surgery procedures.  For more than 50 years, the Company has provided complete radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, nuclear facilities and other industries in which radiation poses a potential threat to employees.  Landauer's services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from customers, and the analysis and reporting of exposure findings.  The Company provides its dosimetry services to approximately 1.8 million individuals globally.  In addition, through its Medical Physics segment, the Company provides therapeutic and imaging physics services to the medical physics community. Through its Medical Products segment, the Company provides medical consumable accessories used in radiology, radiation therapy, and image guided surgery procedures.  For information about Landauer, please visit their website at http://www.landauer.com.

For the latest news releases and other corporate documents on Landauer, Inc., visit www.landauer.com.


'/>"/>
SOURCE Landauer, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Landauer, Inc. Sets Date and Time for Announcement of Fiscal Third Quarter 2014 Results
2. Landauer, Inc. Reports Fiscal 2013 Fourth Quarter And Year End Results
3. Landauer, Inc. Sets Date And Time For Announcement Of Fiscal Fourth Quarter And Full Year 2013 Results
4. Landauer, Inc. Reports Fiscal 2013 Third Quarter Results
5. Landauer, Inc. Declares Regular Cash Dividend
6. Landauer, Inc. Reports Fiscal 2013 Second Quarter Results
7. Landauer, Inc. Sets Date And Time For Announcement Of Fiscal Second Quarter 2013 Results
8. Landauer, Inc. Reports Fiscal 2013 First Quarter Results
9. Landauer, Inc. Reports Fiscal 2012 Fourth Quarter And Year End Results
10. Landauer, Inc. Sets Date And Time For Announcement Of Fiscal Fourth Quarter And Full Year 2012 Results
11. Landauer, Inc. Appoints Ronald Zilkowski To Vice President, Corporate Controller And Chief Accounting Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... -- Research and Markets has announced the addition of the ... ... comprehensive analytics for the US, Canada , ... , Latin America , and Rest of World. Annual ... a six-year historic analysis is provided for these markets. Market data and ...
(Date:2/17/2017)... NEW HAVEN, Conn. , Feb. 17, 2017 /PRNewswire/ ... new class of drugs based on protein degradation, today ... oral androgen receptor (AR) PROTAC during a poster session ... Cancers Symposium (ASCO GU) in Orlando, FL. ... today continue to validate our platform and the potential ...
(Date:2/17/2017)... 2017   Risperdal lawsuits involving gynecomastia (male breast ... use of the atypical antipsychotic medication continue to move ... of Common Pleas, where the state,s Risperdal docket has ... a notice posted on the Court,s website , ... March 9, 2017 at 11:00 a.m. (In Re: Risperdal ...
Breaking Medicine Technology:
(Date:2/19/2017)... ... February 19, 2017 , ... Braun Industries will be ... & Exposition, the event will take place February 23-25, 2017 at the Calvin L. ... in Booth #909 with three new ambulances on display. , “JEMS ...
(Date:2/18/2017)... ... February 17, 2017 , ... Focused start-ups, not ... the industry, according to the recent NEJM Catalyst Insights Report on the New ... NEJM Catalyst Insights Council, a qualified group of U.S. executives, clinical leaders, and ...
(Date:2/18/2017)... ... February 18, 2017 , ... A new directory from ... points to easily connect elderly veterans of America's armed forces to a range ... also conveys material on this year's increase in the Veterans Pension with Aid ...
(Date:2/17/2017)... ... 2017 , ... For the first time, International Scholarship and ... floor for the 2017 HIMSS Conference & Exhibition at the Orange ... than 40,000 healthcare industry professionals are expected at the conference, where they will ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... the HIMSS17 Conference & Exhibition in Orlando, Fla., February 19-23. Visitors to the ... the most widely used electronic patient signatures solution in healthcare . ...
Breaking Medicine News(10 mins):